2556
M. Bosco et al. / Tetrahedron Letters 51 (2010) 2553–2556
8. (a) Thimon, C.; Panza, L.; Morin, C. Synlett 2003, 1399–1402; (b) Ronchi, S.;
Supplementary data
Prosperi, D.; Timon, C.; Morin, C.; Panza, L. Tetrahedron: Asymmetry 2005, 16,
39–44.
Supplementary data associated with this article can be found, in
9. Rat, S.; Mathiron, D.; Michaud, P.; Kovensky, J.; Wadouachi, A. Tetrahedron
2007, 63, 12424–12428.
10. Typical experimental procedure for the preparation of glucuronamide 3f: To a
solution of 6,1-lactone 1 (100 mg, 331 lmol) in dichloromethane (1 mL) was
References and notes
added the dioctylamine 2f (1.2 equiv). Then the reaction mixture was warmed
at 40 °C. After total disappearance of the lactone followed by TLC, the crude
reaction mixture was chromatographed on silica gel (ethyl acetate/
cyclohexane 3:7) to give the corresponding glucuronamide 3f as a colorless
1. Zehl, M.; Pittenauer, E.; Rizzi, A.; Allmaier, G. J. Am. Soc. Mass Spectrom. 2006,
17, 1081–1090.
oil (131 mg,
a d 5.56 (t, 1H, J2–3 = J3–
b:78/22).1H NMR (CDCl3, 300 MHz)
2. (a) Seto, H.; Otake, N.; Sato, S.; Yamaguchi, H.; Takada, K.; Itoh, M.; Lu, H. S. M.;
Clardy, J. Tetrahedron Lett. 1988, 29, 2343–2346; (b) Hotoda, H.; Furukawa, M.;
Daigo, M.; Murayam, K.; Kanako, M.; Muramatsu, Y.; Ishii, M. M.; Miyakoshi, S.;
Takatsu, T.; Inukai, M.; Kakuta, M.; Abe, T.; Harasaki, T.; Fukuoka, T.; Utsui, Y.;
Ohya, S. Bioorg. Med. Chem. Lett. 2003, 13, 2829–2832; (c) Kurosu, M.; Li, K.;
Crick, D. C. Org. Lett. 2009, 11, 2393–2396.
3. (a) Baltina, L. A., Jr.; Kondratenko, R. M.; Baltina, L. A.; Plyasunova, O. A.; Galin,
F. Z.; Tolstikov, G. A. Chem. Nat. Compd. 2006, 42, 543–548; (b) Baltina, L. A., Jr.;
Kondratenko, R. M.; Baltina, L. A.; Baschenko, N. Z.; Pl’yasunova, O. A. Russ. J.
Bioorg. Chem. 2009, 35, 510–517.
4. (a) Vogel, C.; Jeschke, U.; Vill, V.; Fischer, H. Liebigs Ann. Chem. 1992, 11, 1171–
1177; (b) Velasco-Torrijos, T.; Murphy, P. V. Tetrahedron: Asymmetry 2005, 16,
261–272; (c) Temelkoff, D. P.; Zeller, M.; Norris, P. Carbohydr. Res. 2006, 341,
1081–1090; (d) Kondratenko, R. M.; Baltina, L. A.; Gromakova, L. S.; Baltina, L.
A.; Khalilov, L. M.; Nasyrov, Kh. M.; Tolstikov, G. A. Pharm. Chem. J. 2007, 41,
357–361.
4 = 9.4 Hz, H-3), 5.50 (d, 1H, J1–2 = 3.6 Hz, H-1), 5.49 (t, 1H, J3–4 = J4–5 = 9.4 Hz,
H-4), 4.93 (dd, 1H, J1–2 = 3.6 Hz, J2–3 = 9.7 Hz, H-2), 4.83 (d, 1H, J4–5 = 9.4 Hz, H-
5), 4.21 (br s, 1H, H-1COH), 3.43–3.19 (m, 4H, NCH2 Â 2), 2.10 (s, 3H, COCH3),
2.04 (s, 3H, COCH3), 1.97 (s, 3H, COCH3), 1.60–1.46 (m, 4H, NCH2CH2 Â 2), 1.32–
1.24 (m, 20H, CH2 Â 10), 0.88 (t, 6H, J = 6.9 Hz, CH3 Â 2). 13C NMR (CDCl3,
75 MHz) d 170.7, 170.3, 169.0 (3C, COCH3 Â 3), 166.0 (C-6), 90.6 (C-1), 71.2 (C-
2a), 70.3, 70.0 (2C, C-3, C-4), 65.6 (C-5), 47.6 (CH2), 46.6 (CH2), 31.9, 29.5, 29.3,
27.5, 27.0, 26.9, 22.7 (CH2), 20.9, 20.8, 20.7 (3C, COCH3 Â 3), 14.2 (2C, CH3 Â 2).
HRMS calcd for C28H49NO9Na+ [M+Na]+: 566.3305 found m/z: 566.3313.
11. (a) Das, A.; Zhou, Y.; Ivanov, A. A.; Carter, R. L.; Harden, T. K.; Jacobson, K. A.
Bioconjugate Chem. 2009, 20, 1650–1659; (b) Ko, H.; Das, A.; Carter, R. L.; Fricks,
I. P.; Zhou, Y.; Ivanov, A. A.; Melman, A.; Joshi, B. V.; Kovac, P.; Hajduch, J.; Kirk,
K. L.; Harden, T. K.; Jacobson, K. A. Bioorg. Med. Chem. 2009, 17, 5298–5311.
12. Marugg, J. E.; Tromp, M.; Kuyl-Yeheskievly, E.; van der Marel, G. A.; van Boom,
J. H. Tetrahedron Lett. 1986, 27, 2661–2664.
13. Pannecoucke, X.; Schmitt, G.; Luu, B. Tetrahedron 1994, 50, 6569–6578.
14. In the presence of a lewis acid catalyst, such as SnCl4, both C-1 and C-6 can be
substituted by benzylamine as showed previously for alcohols,9 a one-pot
amidification–glycosylation occurred. The benzamide–benzylamine derivative
4c has been obtained in 52% yield.
5. (a) Tosin, M.; Murphy, P. V. Org. Lett. 2002, 4, 3675–3678; (b) Tosin, M.; O’Brien,
C.; Fitzpatrick, G. M.; Mueller-Bunz, H.; Glass, W. K.; Murphy, P. V. J. Org. Chem.
2005, 70, 4096–4106; (c) Mimna, R.; Tuchscherer, G.; Mutter, M. Int. J. Pept. Res.
Ther. 2007, 13, 237–244.
6. (a) Röckendorf, N.; Lindhorst, T. K. J. Org. Chem. 2004, 69, 4441–4445; (b)
McGavin, R. S.; Gagne, R. A.; Chervenak, M. C.; Bundle, D. R. Org. Biomol. Chem.
2005, 3, 2723–2732; (c) D’Onofrio, J.; De Champdore, M.; De Napoli, L.;
Montesarchio, D.; Di Fabio, G. Bioconjugate Chem. 2005, 16, 1299–1309; (d)
Kondratenko, R. M.; Baltina, L. A., Jr.; Baltina, L. A.; Baschenko, N. Zh.; Tolstikov,
G. A. Russ. J. Bioorg. Chem. 2006, 32, 595–601; (e) Doyle, D.; Murphy, P. V.
Carbohydr. Res. 2008, 343, 2535–2544; (f) Bertolla, C.; Rolin, S.; Evrard, B.;
Pochet, L.; Masereel, B. Bioorg. Med. Chem. Lett. 2008, 18, 1855–1858.
7. (a) Guilbot, J.; Benvegnu, T.; Legros, N.; Plusquellec, D. Langmuir 2001, 17, 613–
618; (b) Berchel, M.; Lemiègre, L.; Jeftic, J.; Benvegnu, T. Tetrahedron Lett. 2008,
49, 4690–4692; (c) Berchel, M.; Lemiègre, L.; Trépout, S.; Lambert, O.; Jeftic, J.;
Benvegnu, T. Tetrahedron Lett. 2008, 49, 7419–7422.
O
H
O
O
N
AcO
O
SnCl4
O
PhCH2NH2
AcO
AcO
+
N
H
MW 60°C
15W, 5 min
AcO
4c
OAc
OAc
1
2c
15. (a) Baisch, G.; Öhrlein, R. Bioorg. Med. Chem. 1998, 6, 1673–1682; (b) Schwardt,
O.; Baisch, G.; Öhrlein, R. Bioorg. Med. Chem. 2001, 9, 1857–1869.
16. Crich, D.; Sasaki, K. Org. Lett. 2009, 11, 3514–3517.